Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-23-Speech-2-935"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-11-23"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20101123.33.2-935"2
lpv:hasSubsequent	lp_eu:2010-11-23-Speech-2-2232
lpv:speaker	lp:Nuno Melo2
lpv:spokenAs	member_of_the_bureau; EPP (2009-07-14--2014-06-30)3 member; LIBE (2009-07-16--2012-01-18)3 vice-chair; Delegation for relations with the Mercosur countries (2009-09-30--2014-06-30)3 substitute; Delegation for relations with the Palestinian Legislative Council (2009-09-16--2014-06-30)3 substitute; DROI (2009-07-16--2012-01-18)3 unknown; Partido Popular (2009-07-14--2014-06-30)3 substitute; ECON (2009-07-16--2012-01-18)3 member; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3
lpv:translated text	"The trade in pharmaceutical products is an important part of world trade. The inclusion of a further 718 products on the list for bound duty-free treatment is a beneficial measure, at both an economic and a public health level. The decision to add these products to the 8 619 already on the list may also have an impact on the final price of medicines, which is beneficial for everyone."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph